Fujian Kerui Pharmaceutical Co Ltd DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Virtual Booth

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

ACTIVE PHARMA INGREDIENTS

2 All APIs, 2 USDMF, 2 NDC API

2 All APIs
2 USDMF
2 NDC API

INSPECTIONS & REGISTRATIONS

5 FDA, 1 GDUFA

inspections
5 FDA
1 GDUFA

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Fujian Kerui Pharmaceutical Co., Ltd.(KR) enterprise is a hi-tech pharmaceutical enterprise and a sino-American joint venture by Fujian Intitute of Microbiology (FIM) and an American investor. Relying on the high scientific and technological achievements and the technical personnel of the institute, KR develops, manufactures and markets the drugs produced by microorganisms. The president of KR, Yuanrong Cheng, a distinguished professor of microbiology and biotechnology. He studied and worked at Padova University and Verona University in Italy as well as at MIT in the United States. He is also an editorial member of THE JOURNAL OF ANTIBIOTICS. The business scope of KR is manufacturing and marketing immunomodulators, new antibiotics, traditional Chinese medicines and chemical reagents. The main product, Cyclosporin A, approved by FDA in 1997 has been exported to foreign countries. Cyclosporin A oral solution, CYSPIN, is widely used in the prevention of graft rejection in organ and bone marrow transplantations and the treatment of autoimmune diseases. Being an effective immunosuppressive agent with a price advantage, CYSPIN is well accepted by patients and welcome by physicians. Besides manufacturing a series of Cyclosporin products, Rapamycin, Sirolimus oral solutionto,Mycophenolate mofetil,Tacrolimus,Mizoribine are all our main products. FIM, the technological-supporting institution of KR, is a professional institute mainly engaged in the research and development of new drugs from microbial origin. It has successfully developed new antibiotics such as Gentamicin and Sisomicin by Micromonospora; potent immunosuppresant, Cyclosporin A by fungi;immunoenhancer, N-CWS by Norcardia and β-lactamase inhibitor ,Clavulanic acid by Streptomyces. These have evolved some distinguishing features in searching for new drugs from microorganisms especially from Micromonospora. KR sincerely conducts cooperation with various institutes and enterprises at home and abroad in an effort to make significant contributions to the health of mankind.

Tides AsiaTides Asia

Not Confirmed

Not Confirmed

24-26 February, 2026

Tokyo, Japan
CosmoprofCosmoprof

Not Confirmed

Not Confirmed

27-29 January, 2026

Miami Beach, Florida, U.S.A
HPCI IndiaHPCI India

Not Confirmed

Not Confirmed

27-28 January, 2026

Jio World Convention Centre, Mumbai

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

China

Address

No.25, Jinbu Road, Cangshan, Fuzhou, Fujian 350007

Telephone

+86 591-83470739

enquiries@pharmacompass.com

Website

http://www.fjkerui.com/

YouTube

ALL APIs

Click the button for full data set

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

Only 10 entries up to this point, click to access all

Inspections and registrations

Upload your audits for free, ask us

FDA

01 FDA Audited

USA

IPPE

Not Confirmed

02 FDA Audited

USA

IPPE

Not Confirmed

03 FDA Audited

USA

IPPE

Not Confirmed

04 FDA Audited

USA

IPPE

Not Confirmed

05 FDA Audited

USA

IPPE

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

GDUFA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Fujian Kerui Pharmaceutical Co Ltd and get a quotation

Fujian Kerui Pharmaceutical Co Ltd is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Cyclosporine bulk with DMF offered by Fujian Kerui Pharmaceutical Co Ltd

Find a price of Sirolimus bulk with DMF offered by Fujian Kerui Pharmaceutical Co Ltd

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Company profile for Fujian Kerui Pharmaceutical Co Ltd